Olanzapine pamoate
Drug ingredientCAS 221373-18-8
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
3 FDA-registered drug labelers
Eli Lilly Kinsale Limited
Evonik Corporation
Synergy Health AST, LLC
Why It Matters
Sectors
Health
Downstream UsesNot recorded
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS221373-18-8
PubChem CID135566032
DTXSIDDTXSID50944788
FormulaC40H38N4O7S
Mol. Weight718.8 g/mol
SMILESCC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O.O
Data Sources
- PubChem · compound 135566032Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Olanzapine pamoate (CAS 221373-18-8) https://chemicalindependence.com/chemical/221373-18-8/ PubChem: 135566032. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/135566032 FDA National Drug Code directory: CAS 221373-18-8. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/